Shedding of NKp30 ligands has also been described in chronic lymphocytic leukemia (CLL), in which exosomal expression of BAG6 mediates NK cell activation, whereas soluble BAG6 suppresses NK cell cytotoxicity (95). The gene discussed is BAG6; the disease is B-cell chronic lymphocytic leukemia.